Educational — Not Legal AdviceReviewed
Is IGF-1 legal? FDA status and US regulatory standing
Current status
FDA-approved. IGF-1 is an FDA-approved drug (status recorded ).
Primary source: www.accessdata.fda.gov
Federal legal status
FDA approval status
IGF-1 is an FDA-approved drug. FDA-approved: Increlex (mecasermin, recombinant human IGF-1), Drugs@FDA application 021839.
Also known as
Insulin-like Growth Factor 1 · Somatomedin C · native IGF-1
Status history
- IGF-1 is an FDA-approved drug. [source]
Frequently asked questions
- Is IGF-1 FDA approved?
- IGF-1 is an FDA-approved drug (status recorded 2005-08-30). Primary source linked on this page.
- Is IGF-1 legal to buy?
- IGF-1 is available in the U.S. as a research-use-only compound. It is an FDA-approved drug. Sale for human consumption is not permitted.
PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.
Content review: Regulatory status is sourced from the linked primary records and reviewed by the PeptideBase editorial team. This page is educational — not legal or medical advice. Last reviewed: .